Please login to the form below

heart attack

This page shows the latest heart attack news and features for those working in and with pharma, biotech and healthcare.

treating indicated patients at high risk of cardiovascular events, such as heart attack and stroke,” said Thero.

Novartis plans inclisiran trial in the UK

Novartis also plans to conduct ORION-4, the ongoing study for patients who have already had a heart attack or stroke, with this study making the UK the global trial centre.
AZ says Brilinta hits the mark in new stroke trial

When used on its own by patients who had already suffered a stroke or transient ischaemic attack (TIA), it demonstrated a trend towards fewer subsequent events of stroke, heart attack ... The drug is already approved for the treatment of acute coronary
Novo Nordisk gets MACE prevention claim for Ozempic in US

of major adverse cardiovascular events (MACE) in type 2 diabetes patients with heart disease. ... fatal heart attack or non-fatal stroke by 26% versus placebo when added to standard of care.
UCB/Amgen’s Evenity finally cleared for osteoporosis in Europe

The FDA only gave the go-ahead to the drug with a label warning that it may increase the risk of heart attack, stroke and cardiovascular death, prompting analysts at Jefferies
Amarin files fish oil-based heart drug Vascepa in Europe

The EU filing comes as Vascepa (icosapent ethyl) is also under review by the FDA for a new label claim that the drug can reduce the incidence of heart attack and ... with Vascepa “major adverse cardiovascular events such as stroke, heart attack and

More from news
Approximately 5 fully matching, plus 220 partially matching documents found.

The evolution of marketing – the Amgen way

Yet, cardiovascular disease is still the leading cause of death in Europe, and 80% of premature cases of heart disease and stroke are preventable. ... predict which cardiovascular disease patients are at high risk of a second event, such as a heart attack
Changing direction: adapting to a rapidly-evolving environment

In the era of the algorithm, your doctor can now predict you’ll have a fatal heart attack five years before it hits you. ... If we’re going to exploit the brilliance of technology to change behaviours and transform health outcomes, marketing and
Insights from Cannes Lions Health Festival 2018

sea. He describes the impact – the pain, the chaos and the suffering – and we experience the attack with him through Jaws-style shots. ... The film ends with a big reveal: this wasn’t a shark attack, but a heart attack.
Proving real-world value

Insights reach R&D that ordinarily take years; beta-blockers, for example, found expanded use to control hypertension only after retrospective analysis of four decades of use in heart attack patients.”.
Why health psychology is the answer to tackling adherence

Therapy (OAP), a treatment that has been shown to reduce the risk of death or non-fatal heart attack.

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Understanding the "Big Picture"

In this case, of the male patients with ACS, 27% experienced angina and 73% experienced a heart attack. ... This quickly demonstrates that the majority of male patients who experience a heart attack will be found within the non ST-elevated heart attack

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.